Literature DB >> 31388785

Elevated CSF neurofilament light chain concentration in a patient with facial onset sensory and motor neuronopathy.

Kristin S Lange1, André Maier2, Christoph Leithner3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31388785     DOI： 10.1007/s10072-019-04033-9

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  9 in total

1.  FOSMN syndrome: novel insight into disease pathophysiology.

Authors:  Steve Vucic; Thor D Stein; E Tessa Hedley-Whyte; Stephen R Reddel; Stephen Tisch; Katya Kotschet; Didier Cros; Matthew C Kiernan
Journal:  Neurology       Date:  2012-06-20       Impact factor: 9.910

2.  Cerebrospinal fluid levels of neurofilament light chain in multiple system atrophy relative to Parkinson's disease: a meta-analysis.

Authors:  Xiaohui Hu; Yan Yang; Daokai Gong
Journal:  Neurol Sci       Date:  2016-11-28       Impact factor: 3.307

Review 3.  Facial onset sensory and motor neuronopathy.

Authors:  Qian Zheng; Lan Chu; Liming Tan; Hainan Zhang
Journal:  Neurol Sci       Date:  2016-07-29       Impact factor: 3.307

Review 4.  Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls.

Authors:  Aylin Yilmaz; Kaj Blennow; Lars Hagberg; Staffan Nilsson; Richard W Price; Judith Schouten; Serena Spudich; Jonathan Underwood; Henrik Zetterberg; Magnus Gisslén
Journal:  Expert Rev Mol Diagn       Date:  2017-06-14       Impact factor: 5.225

5.  Cerebrospinal fluid β-amyloid42 and neurofilament light relate to white matter hyperintensities.

Authors:  Katie E Osborn; Dandan Liu; Lauren R Samuels; Elizabeth E Moore; Francis E Cambronero; Lealani Mae Y Acosta; Susan P Bell; Michelle A Babicz; Elizabeth A Gordon; Kimberly R Pechman; L Taylor Davis; Katherine A Gifford; Timothy J Hohman; Kaj Blennow; Henrik Zetterberg; Angela L Jefferson
Journal:  Neurobiol Aging       Date:  2018-04-03       Impact factor: 4.673

Review 6.  Neurofilaments as biomarkers in neurological disorders.

Authors:  Michael Khalil; Charlotte E Teunissen; Markus Otto; Fredrik Piehl; Maria Pia Sormani; Thomas Gattringer; Christian Barro; Ludwig Kappos; Manuel Comabella; Franz Fazekas; Axel Petzold; Kaj Blennow; Henrik Zetterberg; Jens Kuhle
Journal:  Nat Rev Neurol       Date:  2018-10       Impact factor: 42.937

7.  Heterozygous D90A-SOD1 mutation in a patient with facial onset sensory motor neuronopathy (FOSMN) syndrome: a bridge to amyotrophic lateral sclerosis.

Authors:  Eleonora Dalla Bella; Andrea Rigamonti; Vittorio Mantero; Michela Morbin; Stefania Saccucci; Cinzia Gellera; Gabriele Mora; Giuseppe Lauria
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-03-03       Impact factor: 10.154

8.  Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis.

Authors:  Ching-Hua Lu; Corrie Macdonald-Wallis; Elizabeth Gray; Neil Pearce; Axel Petzold; Niklas Norgren; Gavin Giovannoni; Pietro Fratta; Katie Sidle; Mark Fish; Richard Orrell; Robin Howard; Kevin Talbot; Linda Greensmith; Jens Kuhle; Martin R Turner; Andrea Malaspina
Journal:  Neurology       Date:  2015-05-01       Impact factor: 9.910

9.  Facial Onset Sensory and Motor Neuronopathy: Further Evidence for a TDP-43 Proteinopathy.

Authors:  Besa Ziso; Tim L Williams; R Jon L Walters; Stephan R Jaiser; Johannes Attems; Udo C Wieshmann; A J Larner; Anu Jacob
Journal:  Case Rep Neurol       Date:  2015-04-23
  9 in total
  1 in total

Review 1.  Facial Onset Sensory and Motor Neuronopathy: New Cases, Cognitive Changes, and Pathophysiology.

Authors:  Eva M J de Boer; Andrew W Barritt; Marwa Elamin; Stuart J Anderson; Rebecca Broad; Angus Nisbet; H Stephan Goedee; Juan F Vázquez Costa; Johannes Prudlo; Christian A Vedeler; Julio Pardo Fernandez; Mónica Povedano Panades; Maria A Albertí Aguilo; Eleonora Dalla Bella; Giuseppe Lauria; Wladimir B V R Pinto; Paulo V S de Souza; Acary S B Oliveira; Camilo Toro; Joost van Iersel; Malu Parson; Oliver Harschnitz; Leonard H van den Berg; Jan H Veldink; Ammar Al-Chalabi; Peter N Leigh; Michael A van Es
Journal:  Neurol Clin Pract       Date:  2021-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.